Stapedectomy Surgery in India and UAE | Complete Patient Guide

• Confirmed otosclerosis on pure-tone audiometry showing a conductive or mixed hearing loss with an air-bone gap ≥ 20–25 dB HL at two or more frequencies

• Absent or significantly reduced acoustic stapedial reflex on impedance audiometry (tympanometry type As pattern)

• High-resolution CT of the temporal bones demonstrating anterior focus of otosclerosis (halo sign around the cochlea or stapes footplate fixation) and ruling out superior semicircular canal dehiscence or other mimics

• Adequate sensorineural reserve: speech discrimination score ≥ 60% on word recognition testing to justify operative risk to residual cochlear function

• Failure of, or patient preference over, conventional amplification (hearing aids)

• Age typically ≥ 18 years; pediatric cases considered on individual merit

• Medically fit for general or local-with-sedation anesthesia (ASA Class I–III)

Required Pre-operative Diagnostics:

• Pure-tone audiogram (PTA) and speech audiogram (SDS/SRT) — mandatory

• Tympanometry and acoustic reflex testing

• High-resolution CT temporal bones (0.5–1 mm axial and coronal reconstructions)

• MRI internal auditory canal if retrocochlear pathology must be excluded

• Baseline blood panel: CBC, coagulation profile (PT/INR, aPTT), metabolic panel, HbA1c (if diabetic)

• Cardiovascular clearance for patients > 50 years or with comorbidities

Contraindications:

• Only-hearing ear (single functional ear) — high-risk; surgery deferred or performed with extensive counseling

• Active middle-ear infection or tympanic membrane perforation (must be resolved ≥ 3 months prior)

• Severe sensorineural hearing loss with speech discrimination < 60% (poor prognosis for functional gain)

• Obliterative or far-advanced otosclerosis with complete bony infill of the oval window niche

• Menière's disease with concurrent endolymphatic hydrops (relative contraindication; risk of vertigo exacerbation)

• Bleeding diathesis or anticoagulation that cannot be safely bridged perioperatively

• Pregnancy (surgery deferred until postpartum)

• Uncontrolled systemic disease (uncontrolled hypertension, poorly controlled diabetes mellitus, active autoimmune flare)

1. CONVENTIONAL STAPEDECTOMY (Total Footplate Removal)

The historical gold-standard approach involves complete removal of the stapes arch and entire footplate under operating microscope magnification (×10–×40). A vein graft or absorbable gelatin-sponge seal is placed over the oval window, and a stainless-steel, Teflon-platinum, or titanium piston prosthesis (0.4–0.6 mm diameter, 4–4.75 mm length) is crimped to the long process of the incus. This technique is preferred in cases of obliterative footplates or thick bony fixation where small-fenestra techniques are less feasible.

2. SMALL-FENESTRA STAPEDOTOMY (Current Preferred Standard)

Rather than full footplate removal, a precisely calibrated fenestra (0.4–0.8 mm) is drilled or lasered into the footplate center. This minimizes perilymph displacement, reduces risk of sensorineural hearing loss, and allows more predictable prosthesis seating. The piston is crimped to the incus lenticular process. Stapedotomy has largely replaced total stapedectomy in high-volume centers due to superior safety profile.

3. LASER-ASSISTED STAPEDOTOMY

• KTP (532 nm potassium-titanyl-phosphate) laser: Delivers precise, controlled energy to vaporize the footplate center and the posterior crus without mechanical manipulation; minimizes acoustic and thermal trauma to the cochlea.

• CO2 laser (with micromanipulator): Excellent tissue selectivity; non-contact technique reduces risk of footplate fracture.

• Diode laser systems are also employed in some centers.

Laser techniques are the current best-practice standard at tertiary ENT centers, offering reduced operative time, lower risk of floating footplate, and improved prosthesis placement accuracy.

4. ENDOSCOPIC EAR SURGERY (EES) PLATFORM

Transcanal endoscopic stapedotomy using 0° and 45° rigid Hopkins rod endoscopes (3 mm diameter) provides a wide-angle panoramic view of the middle ear without a post-auricular incision. Single-handed technique (endoscope in one hand, instrument in the other) allows visualization of areas obscured by the operating microscope. EES is gaining rapid adoption globally and is offered at leading Indian ENT centers (e.g., Amrita, Medanta, Apollo) and UAE institutions (e.g., Burjeel, Cleveland Clinic Abu Dhabi). It reduces soft-tissue trauma, postoperative pain, and recovery time.

5. REVISION STAPEDECTOMY

Performed when primary surgery fails due to prosthesis displacement, incus erosion, re-fixation, or perilymph fistula. Technically demanding; undertaken by fellowship-trained otologists using CT-guided planning. Success rates in revision cases (70–80%) are lower than primary procedures.

6. PROSTHESIS TECHNOLOGIES

• Titanium pistons (e.g., Kurz, Gyrus): Lightweight, MRI-compatible (safe at 3T with precautions), excellent biocompatibility.

• Nitinol shape-memory alloy pistons: Self-crimping at body temperature, reducing mechanical trauma to the incus during crimping.

• Teflon-platinum pistons: Long-established track record; radiopaque for radiographic identification.

7. ALTERNATIVE — HEARING AMPLIFICATION (Non-surgical)

Conventional or bone-anchored hearing aids (BAHA/Osia) offer non-surgical amplification but do not correct the underlying mechanical defect. Bone-conduction implants are considered in patients who are poor surgical candidates or who decline stapedectomy.

PRE-OPERATIVE PHASE (Weeks –4 to –1):

• Week –4: GAF Healthcare coordinator receives patient's audiogram, CT temporal bone report, and medical records. Remote review by the assigned otologist/otolaryngologist at the partner hospital is arranged.

• Week –3 to –2: Virtual consultation with the surgeon. Prosthesis type, laterality (which ear first if bilateral), and surgical approach (microscopic vs. endoscopic, laser vs. drill) are confirmed. Patient instructed to discontinue aspirin/NSAIDs/anticoagulants 7–10 days pre-op per anesthesia protocol.

• Week –1: Arrival in India or UAE. GAF Healthcare airport transfer arranged. Pre-admission workup completed: repeat PTA, tympanometry, blood panel, anesthesia fitness assessment, and temporal bone CT review by the operating surgeon.

• Day –1: Hospital admission. Informed consent, surgical site marking, anesthesia pre-assessment. Patient is kept nil-by-mouth from midnight.

INTRAOPERATIVE PHASE (Day 0 — Approximately 60–120 minutes):

• Anesthesia: General anesthesia (most common) or local anesthesia with IV sedation (in cooperative adults, particularly for endoscopic approach).

• Positioning: Supine with head turned 30–45° to expose the operative ear.

• Approach: Transcanal (endoscopic or speculum-assisted microscopic) without external incision in most cases; canal wall incision or post-auricular approach reserved for narrow canals.

• Technique: Elevation of tympanomeatal flap → exposure of ossicular chain → confirmation of stapes fixation by palpation → laser or micro-drill footplate fenestration → measurement of prosthesis length (incus to oval window) using calibrated measuring rods → prosthesis placement and crimping → gel foam packing of external canal.

• Intraoperative monitoring: Some advanced centers employ cochlear microphonic monitoring or intraoperative audiometry.

IMMEDIATE POST-OPERATIVE (Days 1–7):

• Day 1: Monitoring for immediate complications — vertigo (transient, expected), nausea, facial nerve function assessment (smile, brow raise, eye closure). Most patients are ambulatory within hours.

• Day 1–2: Discharged from hospital. Ear packed with gel foam or ear wick; patient instructed not to blow nose, sneeze with mouth closed, or immerse ear in water.

• Days 1–7: Mild vertigo and fullness normal. Oral antibiotics (amoxicillin-clavulanate or ciprofloxacin ear drops per surgeon protocol), anti-vertigo medication (betahistine or prochlorperazine as needed).

EARLY RECOVERY (Weeks 1–3 — In-Country Monitoring):

• Week 1 follow-up: Surgeon checks tympanomeatal flap healing, removes outer ear packing. First subjective improvement in hearing often noted by patient at this stage (though gel foam still partially occludes canal).

• Week 2 follow-up: Canal packing fully removed if healed. Audiogram performed to document early hearing gain. The air-bone gap closure is assessed.

• Week 3: Formal fit-to-fly assessment. Patient is cleared for international air travel ONLY if: no active vertigo, no perilymph fistula signs (sudden hearing fluctuation, autophony), and surgeon is satisfied with healing. Pressure equalization on aircraft descent is a risk; patients are advised to use Valsalva cautiously or use Otovent devices during flight.

LONG-TERM RECOVERY (Weeks 4–12 and beyond):

• Weeks 4–6: Audiogram shows near-final functional result; most patients achieve air-bone gap closure to < 10 dB HL.

• Week 6–8: Return to normal physical activity including exercise, travel, and work.

• 3-month audiogram: Gold-standard outcome assessment. Closure of the air-bone gap to ≤ 10 dB HL at 500, 1000, 2000, and 3000 Hz is the benchmark for surgical success.

• If bilateral otosclerosis: Contralateral ear surgery is typically deferred 6–12 months to allow full recovery and confirm outcome of first ear.

• Long-term: Annual audiometric follow-up recommended to monitor for sensorineural deterioration (rare prosthesis-related) or progressive cochlear otosclerosis.